期刊文献+

丙戊酸钠静脉注射治疗癫痫持续状态 被引量:5

Intravenous sodium valproate in treatment of status epilepticus
下载PDF
导出
摘要 目的 :探讨丙戊酸钠注射液治疗癫痫持续状态的疗效和安全性。方法 :丙戊酸钠组 (n =19)和地西泮组 (n =2 2 ) ,均在负荷量丙戊酸钠 10~ 15mg·kg- 1或地西泮 10~ 2 0mg推注后 ,继续 2 4h维持治疗 (分别为 1mg·kg- 1·h- 1和 0 .1~ 0 .2mg·kg- 1·h- 1) ,观察其抗癫痫状态的疗效和不良反应。结果 :丙戊酸钠组和地西泮组起效时间为 (2 3±s18)min和 (7± 5 )min(P <0 .0 1) ,有效率分别为4 7%和 73% (P >0 .0 5 )。丙戊酸钠对不同的癫痫状态类型的疗效无显著差异 (P >0 .0 5 )。丙戊酸钠组治疗前后的生命体征无明显变化 ,血、尿常规 ,肝、肾功能及心电图也无明显改变 ,癫痫状态控制后 ,意识恢复较地西泮组快。结论 :丙戊酸钠注射液治疗癫痫状态有效 。 AIM: To investigate the efficacy and safety of intravenous sodium valproate therapy in the patients with status epilepticus. METHODS:Nineteen patients in intravenous sodium valproate group and twenty-two patients in diazepam group received a loading dose (sodium valproate 10-15 mg·kg -1 or diazepam 10-20 mg) and then a continuous infusion (sodium valproate 1 mg·kg -1·h -1 or diazepam 0.1-0.2 mg·kg -1·h -1) for 24 h.The effect and adverse reactions were observed. RESULTS: Clinical status epilepticus stopped in nine of nineteen patients(47%) in intravenous sodium valparoate group and sixteen of twenty-two patients(73%) in diazepam group. There was no significant difference(P> 0.05). Status epilepticus interrupted in (23±18) min in intravenous sodium valproate group and (7±5) min in diazepam group, respectively(P< 0.05). The effects of sodium valproate for different types of status epilepticus were not different(P> 0.05). All patients were closely monitored during and after sodium valproate infusion. There were no changes of vital sign, blood and urine routine, kidney and liver function, and ECG. Consciousness recovered more rapidly in sodium valproate group than that in diazepam group. CONCLUSION:Intravenous sodium valproate seems safe and effective for the status epilepticus, especially for status epilepticus patients with critical ills.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2003年第7期417-420,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 丙戊酸钠 静脉注射法 癫痫持续状态 地西泮 epilepsies, partial status epilepticus sodium valproate anticonvulsants
  • 相关文献

参考文献8

  • 1CZAPINSKI P, TERCZYNSKI A. Intravenous valproic acid administration in status epilepticus[J]. Neurol Neuroehir Pol, 1998,32(1) : 11-22.
  • 2UBERALL MA, TROLLMANN R, WUNSIEDLER U, et al.Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus[J]. Neurology, 2000, 54(6) :2188-2189.
  • 3MITCHELL WG. Status epileticus and acute repatitive seizures in children, and young adults: etiology, outcome, and treatment[J].Epilepsia, 1996, 37 Suppl 1:74-80.
  • 4DELGADO-ESECUETA AV, FONG CY. Status epilepticus: recent trends and prospects[J]. Neurologia, 1997, 12 Suppl 6:62-73.
  • 5SHETH AD, GIDAL BE. Intravenous vaiproic acid for myoclonic status epilepticua[J]. Neurology, 2000, 54(3) : 1201.
  • 6KAPLAN PW. Intravenous valproate treatment of generalized non-convulsive status epilepticus[JJ. Clin Electroencephalogr, 1999, 30(1):1-4.
  • 7SINHA S, NARITOKU DN. Intravenous valproate is well tolerated in unstable patients with status epilepticus [ J ]. Neunology,2000, 55(6) :722-724.
  • 8VENKATARAMAN V, WHELESS JW. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients[J ].Epilepsy Res, 1999,35(2) : 147-153.

同被引文献49

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部